Furthermore, the expression of CD27, a member of the tumor necrosis factor receptor superfamily, has been associated with immune modulation in cancer, with its ligand CD70 being regulated by hypoxia-inducible factors in renal cell carcinoma (64). Here, CD27 is linked to cancer.